NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,363,000 | -10.7% | 46,166 | -3.2% | 0.66% | -13.0% |
Q3 2016 | $3,767,000 | -3.6% | 47,702 | +0.7% | 0.76% | -4.1% |
Q2 2016 | $3,907,000 | +16.9% | 47,355 | +2.6% | 0.80% | +8.9% |
Q1 2016 | $3,343,000 | -9.8% | 46,152 | +7.1% | 0.73% | -10.7% |
Q4 2015 | $3,707,000 | -3.7% | 43,086 | +2.9% | 0.82% | -9.7% |
Q3 2015 | $3,849,000 | -9.0% | 41,876 | -2.7% | 0.91% | -1.9% |
Q2 2015 | $4,231,000 | +3.3% | 43,022 | +3.6% | 0.93% | +1.5% |
Q1 2015 | $4,095,000 | +10.1% | 41,528 | +3.5% | 0.91% | +12.0% |
Q4 2014 | $3,719,000 | +0.4% | 40,138 | +2.0% | 0.81% | -6.1% |
Q3 2014 | $3,706,000 | +6.7% | 39,368 | +2.6% | 0.87% | +3.1% |
Q2 2014 | $3,472,000 | +3.8% | 38,359 | -2.5% | 0.84% | -2.4% |
Q1 2014 | $3,344,000 | +9.2% | 39,333 | +3.2% | 0.86% | +6.6% |
Q4 2013 | $3,062,000 | +8.4% | 38,100 | +3.5% | 0.81% | +6.3% |
Q3 2013 | $2,824,000 | +12.9% | 36,818 | +4.1% | 0.76% | +3.8% |
Q2 2013 | $2,501,000 | – | 35,383 | – | 0.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |